首页> 外文期刊>Genetic testing and molecular biomarkers >Rapid Detection of G1138A and G1138C Mutations of the FGFR3 Gene in Patients with Achondroplasia Using High-Resolution Melting Analysis
【24h】

Rapid Detection of G1138A and G1138C Mutations of the FGFR3 Gene in Patients with Achondroplasia Using High-Resolution Melting Analysis

机译:高分辨率融解分析快速检测软骨发育不全患者FGFR3基因的G1138A和G1138C突变

获取原文
获取原文并翻译 | 示例
           

摘要

Achondroplasia (ACH) is a genetic disorder with autosomal dominant inheritance and is the cause of one of the most common forms of short limb dwarfism in humans. Mutations of special sites in the fibroblast growth factor receptor-3 gene (FGFR3) are reported as a cause of ACH, and almost 98% of cases are caused by mutations in nucleotide 1138 (Gly380Arg), with 97% involving a c.H38G>A mutation and 1% involving a c.H38G>C mutation. Therefore, the development of a simple, reliable, and rapid approach for molecular detection of nucleotide 1138 mutations is of great significance for prevention and early diagnosis of.ACH. High-resolution melting (HRM) is a new, rapid, and inexpensive molecular detection method that has been generally applied to mutation scanning. In this study, 12 cases of ACH, including 10 sporadic cases and 2 cases in a pedigree, were detected simultaneously using HRM analysis and restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR). Eleven cases were identified as carrying the c.1138 G > A heterozygous mutation, and one case was identified as carrying the c.1138 G>C heterozygous mutation. Compared with RFLP-PCR, HRM analysis provided a more rapid, simpler, and less expensive approach for detecting the most common FGFR3 mutations carried by patients with ACH.
机译:软骨病(ACH)是一种具有常染色体显性遗传的遗传疾病,是人类短肢侏儒症最常见形式之一。据报道,成纤维细胞生长因子受体3基因(FGFR3)特殊位点的突变是ACH的病因,几乎98%的病例是由核苷酸1138(Gly380Arg)突变引起的,其中97%涉及c.H38G>一个突变,涉及c.H38G> C突变的占1%。因此,开发一种简单,可靠,快速的分子检测1138核苷酸突变的方法对ACH的预防和早期诊断具有重要意义。高分辨率熔解(HRM)是一种新的,快速且便宜的分子检测方法,已普遍应用于突变扫描。在这项研究中,使用HRM分析和限制性片段长度多态性聚合酶链反应(RFLP-PCR)同时检测了12例ACH,包括10例散发病例和2例系谱。确定11例携带c.1138 G> A杂合突变,1例携带c.1138 G> C杂合突变。与RFLP-PCR相比,HRM分析提供了一种更快,更简单,更便宜的方法来检测ACH患者携带的最常见FGFR3突变。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2012年第4期|p.297-301|共5页
  • 作者

    Xiang He; Feng Xie; Zhao-rui Ren;

  • 作者单位

    Shanghai Institute of Medical Genetics, Children's Hospital of Shanghai, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.,Key Lab of Embryo Molecular Biology, Ministry of Health, China, and Shanghai Lab of Embryo and Reproduction Engineering, Shanghai, People's Republic of China;

    Department of Orthopedics, Children's Hospital of Shanghai, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China;

    Key Lab of Embryo Molecular Biology, Ministry of Health, China, and Shanghai Lab of Embryo and Reproduction Engineering, Shanghai, People's Republic of China.,Shanghai Institute of Medical Genetics Children's Hospital of Shanghai Shanghai Jiao Tong University School of Medicine 24/1400 West Beijing Road Shanghai 200040 People's Republic of China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号